Zacharias Isaac's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Dec 28, 2023
- Accession no.
- 0001642545-23-000055
- Filed
- Dec 28, 2023
- Trade date
- Dec 26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $770.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zacharias IsaacCIK 0001768265 | Officer (President, CCO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Common Stock | MOption exerciseAcquired | +3,458 | $6.71 | +$23,203.18 | 45,606 | Direct | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −4,000 | $192.50F2 | −$770,000 | 41,606 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Common Stock | MOption exerciseDisposed | −3,458 | $0.00 | $0 | 40,408 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
All reported securities were sold at a price of $192.50.
Referenced by the price of 1 transaction in Table I.